U.S. market Open. Closes in 3 hours 56 minutes

TBIO | Telesis Bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue27.51M27.43M11.04M6.58M4.80M1.42MN/AN/A
Cost of Revenue10.56M11.84M6.74M2.95M8.89MN/AN/AN/A
Gross Profit16.95M15.60M4.30M3.62M-4.08M1.42MN/AN/A
Operating Expenses63.49M62.08M39.67M19.99M2.89M80.63M61.33M26.80M
Selling, General & Admin34.60M38.62M25.12M11.06M1.57M22.61M14.31M11.14M
Research & Development17.50M23.46M14.55M8.93M1.32M58.02M47.02M15.66M
Other Operating Expenses11.39M-26.00K-62.00K-74.00KN/AN/AN/AN/A
Operating Income-46.54M-46.48M-35.37M-16.36M-6.98M-102.96M-78.92M-26.70M
Other Expenses / Income-1.16M-1.96M-3.57M-1.64M-1.33MN/AN/AN/A
Before Tax Income-47.70M-48.45M-38.94M-18.00M-8.30M-102.96M-78.92M-26.70M
Income Tax Expenses24.00K24.00K14.00K5.00K-486.00K-5.57M-12.48M707.18K
Net Income-47.72M-48.47M-38.96M-18.01M-8.30M-97.39M-66.44M-26.70M
Interest Expenses3.10M1.22M1.37M690.00K1.49MN/AN/AN/A
Basic Shares Outstanding29.85M29.46M29.32M29.23M40.76M45.00M29.86M29.86M
Diluted Shares Outstanding1.66M29.46M29.32M29.23M40.76M45.00M29.86M29.86M
EBITDA-40.49M-43.62M-36.00M-15.49M-6.12M-100.12M-77.34M-25.97M
EBITDA Margin-147.20%-158.98%-326.01%-235.63%-127.35%-7,050.63%0.00%0.00%
EBIT-44.59M-47.23M-37.58M-17.32M-7.30M-102.96M-78.92M-25.99M
EBIT Margin-162.11%-172.15%-340.26%-263.31%-151.88%-7,250.70%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙